<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00350220</url>
  </required_header>
  <id_info>
    <org_study_id>12408</org_study_id>
    <nct_id>NCT00350220</nct_id>
  </id_info>
  <brief_title>Transfusion Strategies in Pediatric Cardiothoracic Surgery</brief_title>
  <official_title>A Prospective, Randomized, Controlled Clinical Trial Comparing Two Transfusion Strategies in Pediatric Patients Undergoing Cavopulmonary Connection.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the best red blood cell(hemoglobin) level for
      infants and children following surgical repair of particular heart defects. These children
      often receive red blood cell transfusions after surgery, but what the best hemoglobin level
      is for them remains unknown.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To compare mean post-operative arterial lactate levels, oxygen utilization, and
      outcome measures in pediatric patients undergoing cavopulmonary connection managed with two
      different red blood cell transfusion strategies.

      Methods: We propose a prospective, randomized clinical trial of sixty-six pediatric patients
      with cyanotic, complex congenital cardiac disease undergoing cavopulmonary connection as
      their operative repair. Thirty-three patients will be randomly assigned to a low Hb strategy
      of transfusion, in which red cells are transfused if the hemoglobin concentration falls below
      9.0 g/dL, and hemoglobin concentrations are maintained about 8.5 g/dL. Thirty-three
      additional patients will be randomly assigned to the high Hb transfusion strategy, where red
      cells are transfused if the hemoglobin concentration falls below 13.0 g/dL, and hemoglobin
      concentrations are maintained about 12.5 g/dL. The primary endpoint will be comparison of
      mean arterial lactate levels from 8 to 72 hours post-operatively. The secondary endpoints
      will be oxygen utilization reflected by the arterio-venous oxygen difference (AV-difference)
      and arterio-cerebral oxygen difference (AC-difference). Measures of oxygen utilization will
      be derived from arterial oxygen saturation (SaO2), mixed venous oxygen saturation (SvO2), and
      cerebral oxygen saturation (ScO2) collected at various time points throughout the study.
      Tertiary outcome measures will be length of mechanical ventilation, length of oxygen use and
      of vasoactive agent administration, length pediatric cardiac intensive care unit (PCICU)
      admission, volume of blood transfused, and mortality. Data from each group will be compared
      using analysis of variance to assess for the presence of a difference between the two
      transfusion strategies. If a significant difference between the two groups exists, T-tests
      will be performed to compare data points between each group to assess for a significant
      difference.

      Hypothesis: A more restrictive (low Hb) strategy of red cell transfusion will be as effective
      as, and possibly superior to, the historical (high Hb) approach. Allowing a lower Hb
      concentration will decrease RBC donor exposure and may decrease the known complications of
      RBC transfusions. We postulate that no significant difference will exist between the two
      transfusion groups in regards to hemodynamic and cardiopulmonary status (as evidenced by mean
      lactate levels) and oxygen utilization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Arterial Lactate Level</measure>
    <time_frame>48 hours</time_frame>
    <description>Mean arterial lactate for the first 48 hours post-op.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Arterial Lactate Level</measure>
    <time_frame>48 hours</time_frame>
    <description>Peak arterial lactate level for the 48 hour post-op study period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen Utilization During the 8 Hour to 72 Hours Post-operative Period.</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Mechanical Ventilation</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Oxygen Use</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Vasoactive Agent Administration</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Blood Transfused</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality Before Hospital Discharge</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High Hemoglobin group; goal Hb &gt;13g/dl. 10cc/kg RBCs are transfused for any hemoglobin value under 13g/dl regardless whether clinical indication for transfusion exists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low Hb transfusion group; goal to not transfuse unless the Hb &lt;9.0 g/dl. 10cc/kg RBCs are transfused only if the Hemoglobin is under 9.0g/dl and clinical indications for transfusion exist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>transfusion strategy</intervention_name>
    <description>For the High Hb group; transfusions will be given to keep the Hb &gt;13.0 g/dl</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Hb transfusion group</intervention_name>
    <description>RBCs will not be transfused unless the Hb &lt; 9.0 g/dl</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  4 months to 6.99 years of age

          -  surgical candidates for cavopulmonary connection

          -  English speaking

        Exclusion Criteria:

          -  presence of known bleeding disorder

          -  presence of known coagulopathy

          -  age &lt; 4 months

          -  age &gt; 7 years

          -  non-English speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Months</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jill M Cholette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2006</study_first_submitted>
  <study_first_submitted_qc>July 5, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2006</study_first_posted>
  <results_first_submitted>January 19, 2010</results_first_submitted>
  <results_first_submitted_qc>February 11, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 25, 2010</results_first_posted>
  <last_update_submitted>May 29, 2015</last_update_submitted>
  <last_update_submitted_qc>May 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>jill cholette</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Single ventricle</keyword>
  <keyword>Bidirectional Glenn</keyword>
  <keyword>Fontan</keyword>
  <keyword>Congenital cardiac disease</keyword>
  <keyword>Red blood cell transfusion</keyword>
  <keyword>oxygen utilization</keyword>
  <keyword>lactate level</keyword>
  <keyword>hemoglobin level</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>High Hemoglobin (Liberal) Group</title>
          <description>High Hemoglobin group; goal Hb &gt;13g/dl. RBCs transfused for any Hemoglobin under 13g/dl regardless clinical indications for transfusion.</description>
        </group>
        <group group_id="P2">
          <title>Low Hb (Restrictive) Group</title>
          <description>Low Hb transfusion group; RBCs are not transfused unless the Hb &lt;9.0 g/dl and clinical indications for transfusion are met.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Hemoglobin (Liberal) Group</title>
          <description>High Hemoglobin group; goal Hb &gt;13g/dl. RBCs transfused for any Hemoglobin under 13g/dl regardless clinical indications for transfusion.</description>
        </group>
        <group group_id="B2">
          <title>Low Hb (Restrictive) Group</title>
          <description>Low Hb transfusion group; RBCs are not transfused unless the Hb &lt;9.0 g/dl and clinical indications for transfusion are met.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>subjects under 8 years of age included</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.75" spread="1.9"/>
                    <measurement group_id="B2" value="2.25" spread="1.8"/>
                    <measurement group_id="B3" value="2.5" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Arterial Lactate Level</title>
        <description>Mean arterial lactate for the first 48 hours post-op.</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Hemoglobin (Liberal) Group</title>
            <description>High Hemoglobin group; goal Hb &gt;13g/dl. RBCs transfused for any Hemoglobin under 13g/dl regardless clinical indications for transfusion.</description>
          </group>
          <group group_id="O2">
            <title>Low Hb (Restrictive) Group</title>
            <description>Low Hb transfusion group; RBCs are not transfused unless the Hb &lt;9.0 g/dl and clinical indications for transfusion are met.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Lactate Level</title>
          <description>Mean arterial lactate for the first 48 hours post-op.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.4"/>
                    <measurement group_id="O2" value="1.4" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Utilization During the 8 Hour to 72 Hours Post-operative Period.</title>
        <time_frame>3 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Mechanical Ventilation</title>
        <time_frame>3 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Oxygen Use</title>
        <time_frame>3 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Vasoactive Agent Administration</title>
        <time_frame>3 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume of Blood Transfused</title>
        <time_frame>3 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality Before Hospital Discharge</title>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Peak Arterial Lactate Level</title>
        <description>Peak arterial lactate level for the 48 hour post-op study period.</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Hemoglobin (Liberal) Group</title>
            <description>High Hemoglobin group; goal Hb &gt;13g/dl. RBCs transfused for any Hemoglobin under 13g/dl regardless clinical indications for transfusion.</description>
          </group>
          <group group_id="O2">
            <title>Low Hb (Restrictive) Group</title>
            <description>Low Hb transfusion group; RBCs are not transfused unless the Hb &lt;9.0 g/dl and clinical indications for transfusion are met.</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Arterial Lactate Level</title>
          <description>Peak arterial lactate level for the 48 hour post-op study period.</description>
          <units>mmol/l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.3"/>
                    <measurement group_id="O2" value="3.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>High Hemoglobin (Liberal) Group</title>
          <description>High Hemoglobin group; goal Hb &gt;13g/dl. RBCs transfused for any Hemoglobin under 13g/dl regardless clinical indications for transfusion.</description>
        </group>
        <group group_id="E2">
          <title>Low Hb (Restrictive) Group</title>
          <description>Low Hb transfusion group; RBCs are not transfused unless the Hb &lt;9.0 g/dl and clinical indications for transfusion are met.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There were no limitations to this study. There was 100% compliance with study procedures. There were no adverse events.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jill M. Cholette MD</name_or_title>
      <organization>University of Rochester Medical Center</organization>
      <phone>585-275-0189</phone>
      <email>Jill_Cholette@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

